These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 28262021)

  • 1. Synthesis of the γ-Secretase Modulator MK-8428.
    Miller SP; Morris WJ; Orr RK; Eckert J; Milan J; Maust M; Cowden C; Cui J
    J Org Chem; 2017 Mar; 82(6):2957-2964. PubMed ID: 28262021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diamide amino-imidazoles: a novel series of γ-secretase inhibitors for the treatment of Alzheimer's disease.
    Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Van Deusen JW; Wood DE; Wood KM
    Bioorg Med Chem Lett; 2011 May; 21(9):2631-6. PubMed ID: 21269825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and in vivo characterization of a novel series of tetralin amino imidazoles as γ-secretase inhibitors: discovery of PF-3084014.
    Brodney MA; Auperin DD; Becker SL; Bronk BS; Brown TM; Coffman KJ; Finley JE; Hicks CD; Karmilowicz MJ; Lanz TA; Liston D; Liu X; Martin BA; Nelson RB; Nolan CE; Oborski CE; Parker CP; Richter KE; Pozdnyakov N; Sahagan BG; Schachter JB; Sokolowski SA; Tate B; Wood DE; Wood KM; Van Deusen JW; Zhang L
    Bioorg Med Chem Lett; 2011 May; 21(9):2637-40. PubMed ID: 21269827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors.
    Nowak P; Cole DC; Aulabaugh A; Bard J; Chopra R; Cowling R; Fan KY; Hu B; Jacobsen S; Jani M; Jin G; Lo MC; Malamas MS; Manas ES; Narasimhan R; Reinhart P; Robichaud AJ; Stock JR; Subrath J; Svenson K; Turner J; Wagner E; Zhou P; Ellingboe JW
    Bioorg Med Chem Lett; 2010 Jan; 20(2):632-5. PubMed ID: 19959359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.
    Guo T; Gu H; Hobbs DW; Rokosz LL; Stauffer TM; Jacob B; Clader JW
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3010-3. PubMed ID: 17418571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR study of tricyclic sulfones as γ-secretase inhibitors: C-6 and C-8 positions.
    Su J; Tang H; McKittrick BA; Xu R; Clader JW; Greenlee WJ; Hyde L; Zhang L
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3447-51. PubMed ID: 21515050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a 6-CF
    Oguma T; Anan K; Suzuki S; Hisakawa S; Takada A; Ogawa M; Kusakabe KI
    J Org Chem; 2019 Apr; 84(8):4893-4897. PubMed ID: 30371078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.
    Sevalle J; Ayral E; Hernandez JF; Martinez J; Checler F
    J Neurochem; 2009 Jul; 110(1):275-83. PubMed ID: 19457123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and structure-activity relationship studies of N-arylsulfonyl morpholines as γ-secretase inhibitors.
    Li H; Xu R; Cole D; Clader JW; Greenlee WJ; Nomeir AA; Song L; Zhang L
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6606-9. PubMed ID: 20933414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.
    Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical asymmetric synthesis of a gamma-secretase inhibitor exploiting substrate-controlled intramolecular nitrile oxide-olefin cycloaddition.
    Scott JP; Oliver SF; Brands KM; Brewer SE; Davies AJ; Gibb AD; Hands D; Keen SP; Sheen FJ; Reamer RA; Wilson RD; Dolling UH
    J Org Chem; 2006 Apr; 71(8):3086-92. PubMed ID: 16599604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyridine-derived γ-secretase modulators.
    Wan Z; Hall A; Sang Y; Xiang JN; Yang E; Smith B; Harrison DC; Yang G; Yu H; Price HS; Wang J; Hawkins J; Lau LF; Johnson MR; Li T; Zhao W; Mitchell WL; Su X; Zhang X; Zhou Y; Jin Y; Tong Z; Cheng Z; Hussain I; Elliott JD; Matsuoka Y
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4832-5. PubMed ID: 21742495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.
    Aubele DL; Truong AP; Dressen DB; Probst GD; Bowers S; Mattson MN; Semko CM; Sun M; Garofalo AW; Konradi AW; Sham HL; Zmolek W; Wong K; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Nguyen L; Bova MP; Hemphill SS; Basi G
    Bioorg Med Chem Lett; 2011 Oct; 21(19):5791-4. PubMed ID: 21885276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.
    Bakshi P; Jin C; Broutin P; Berhane B; Reed J; Mullan M
    Bioorg Med Chem; 2009 Dec; 17(23):8102-12. PubMed ID: 19853461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. β-Secretase (BACE1) inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer's disease.
    Hilpert H; Guba W; Woltering TJ; Wostl W; Pinard E; Mauser H; Mayweg AV; Rogers-Evans M; Humm R; Krummenacher D; Muser T; Schnider C; Jacobsen H; Ozmen L; Bergadano A; Banner DW; Hochstrasser R; Kuglstatter A; David-Pierson P; Fischer H; Polara A; Narquizian R
    J Med Chem; 2013 May; 56(10):3980-95. PubMed ID: 23590342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suspected limited efficacy of γ-secretase modulators.
    Kakuda N; Akazawa K; Hatsuta H; Murayama S; Ihara Y;
    Neurobiol Aging; 2013 Apr; 34(4):1101-4. PubMed ID: 23058852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of phosphino dipeptide isostere inhibitor of human beta-secretase (BACE1).
    Manzenrieder F; Frank AO; Huber T; Dorner-Ciossek C; Kessler H
    Bioorg Med Chem; 2007 Jun; 15(12):4136-43. PubMed ID: 17433698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amino-caprolactam γ-secretase inhibitors showing potential for the treatment of Alzheimer's disease.
    Neitzel ML; Aubele DL; Marugg JL; Jagodzinski JJ; Konradi AW; Pleiss MA; Szoke B; Zmolek W; Goldbach E; Quinn KP; Sauer JM; Brigham EF; Wallace W; Bova MP; Hemphill S; Basi G
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3715-20. PubMed ID: 21571529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The γ-secretase blocker DAPT impairs recovery from lipopolysaccharide-induced inflammation in rat brain.
    Nasoohi S; Hemmati AA; Moradi F; Ahmadiani A
    Neuroscience; 2012 May; 210():99-109. PubMed ID: 22445932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and SAR analysis of potent BACE1 inhibitors: Possible lead drug candidates for Alzheimer's disease.
    Tarazi H; Odeh RA; Al-Qawasmeh R; Yousef IA; Voelter W; Al-Tel TH
    Eur J Med Chem; 2017 Jan; 125():1213-1224. PubMed ID: 27871037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.